inprens

Morepen Laboratories Limited

NSE:MOREPENLAB   MOREPEN LABORATORI
PROS

Company has reduced debt.
Company is almost debt free.
Company is expected to give good quarter
Company has delivered good profit growth of 41.36% CAGR over last 5 years
Promoter holding has increased by 3.84% over last quarter.

CONS

Stock is trading at 5.40 times its book value
Though the company is reporting repeated profits, it is not paying out dividend
Feragatname

Bilgiler ve yayınlar, TradingView tarafından sağlanan veya onaylanan finansal, yatırım, işlem veya diğer türden tavsiye veya tavsiyeler anlamına gelmez ve teşkil etmez. Kullanım Şartları'nda daha fazlasını okuyun.